Caldwell Sutter Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$592K Sell
1,636
-43
-3% -$14.7K 0.22% 108
2026
Q1
$591K Sell
1,679
-85
-5% -$30.3K 0.24% 102
2025
Q4
$577K Buy
1,764
+3
+0.2% +$952 0.24% 103
2025
Q3
$497K Buy
1,761
+43
+3% +$12.5K 0.21% 117
2025
Q2
$480K Buy
1,718
+25
+1% +$7.08K 0.22% 115
2025
Q1
$527K Sell
1,693
-87
-5% -$25.7K 0.25% 109
2024
Q4
$464K Sell
1,780
-1
-0.1% -$297 0.22% 117
2024
Q3
$574K Sell
1,781
-67
-4% -$21.9K 0.27% 101
2024
Q2
$577K Sell
1,848
-104
-5% -$30.6K 0.29% 96
2024
Q1
$555K Sell
1,952
-82
-4% -$24K 0.27% 100
2023
Q4
$586K Buy
2,034
+16
+0.8% +$4.36K 0.3% 96
2023
Q3
$542K Sell
2,018
-27
-1% -$6.74K 0.3% 91
2023
Q2
$454K Buy
2,045
+1,183
+137% +$275K 0.24% 105
2023
Q1
$208K Buy
+862
New +$212K 0.15% 117

Other funds holding AMGN

Caldwell Sutter Capital's AMGN Position: Q2 2026 in Review

Caldwell Sutter Capital reduced its Amgen (AMGN) stake by 2.6% in Q2 2026, selling an estimated $14.7K and leaving 1,636 shares worth $592K. The position accounts for 0.22% of the portfolio, ranked #108.

Caldwell Sutter Capital first reported a position in AMGN in Q1 2023 and has held it in 14 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Caldwell Sutter Capital held 1,636 shares of Amgen worth $592K as of Q2 2026.
  • Caldwell Sutter Capital sold 43 Amgen shares in Q2 2026, an estimated $14.7K.
  • Amgen made up 0.22% of Caldwell Sutter Capital's portfolio in Q2 2026, its #108 holding.
  • Caldwell Sutter Capital first reported a position in Amgen in Q1 2023 and has held it in 14 quarters since.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.